1. Home
  2. AUTL vs REAX Comparison

AUTL vs REAX Comparison

Compare AUTL & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

HOLD

Current Price

$1.53

Market Cap

388.6M

Sector

Health Care

ML Signal

HOLD

Logo The Real Brokerage Inc.

REAX

The Real Brokerage Inc.

HOLD

Current Price

$1.76

Market Cap

386.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUTL
REAX
Founded
2014
2018
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
388.6M
386.3M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
AUTL
REAX
Price
$1.53
$1.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$8.50
$5.49
AVG Volume (30 Days)
1.2M
3.2M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,120,000.00
N/A
Revenue This Year
$80.32
$23.04
Revenue Next Year
$53.96
$15.98
P/E Ratio
N/A
N/A
Revenue Growth
496.00
N/A
52 Week Low
$1.18
$1.55
52 Week High
$2.70
$5.41

Technical Indicators

Market Signals
Indicator
AUTL
REAX
Relative Strength Index (RSI) 46.27 47.31
Support Level $1.41 $1.59
Resistance Level $1.73 $1.86
Average True Range (ATR) 0.12 0.10
MACD -0.02 0.03
Stochastic Oscillator 29.54 64.52

Price Performance

Historical Comparison
AUTL
REAX

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

Share on Social Networks: